Warm autoimmune hemolytic anemia

From HemOnc.org - A Hematology Oncology Wiki
Revision as of 14:09, 1 October 2019 by Jwarner (talk | contribs)
Jump to navigation Jump to search
Section editor
Tillman Benjamin-2.jpg
Benjamin Tillman, MD
Vanderbilt University
Nashville, TN
4 regimens on this page
3 variants on this page


Guidelines

British Society for Haematology

All lines of therapy

Prednisolone monotherapy

back to top

Regimen

Study Evidence Comparator Efficacy
Birgens et al. 2013 Phase III (C) Prednisolone & Rituximab Seems to have inferior RFS

Immunosuppressive therapy

References

  1. Birgens H, Frederiksen H, Hasselbalch HC, Rasmussen IH, Nielsen OJ, Kjeldsen L, Larsen H, Mourits-Andersen T, Plesner T, Rønnov-Jessen D, Vestergaard H, Klausen TW, Schöllkopf C. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol. 2013 Nov;163(3):393-9. Epub 2013 Aug 24. link to original article PubMed

Prednisolone & Rituximab

back to top

Regimen

Study Evidence Comparator Efficacy
Birgens et al. 2013 Phase III (E) Prednisolone Seems to have superior RFS

Immunosuppressive therapy

References

  1. Birgens H, Frederiksen H, Hasselbalch HC, Rasmussen IH, Nielsen OJ, Kjeldsen L, Larsen H, Mourits-Andersen T, Plesner T, Rønnov-Jessen D, Vestergaard H, Klausen TW, Schöllkopf C. A phase III randomized trial comparing glucocorticoid monotherapy versus glucocorticoid and rituximab in patients with autoimmune haemolytic anaemia. Br J Haematol. 2013 Nov;163(3):393-9. Epub 2013 Aug 24. link to original article PubMed